These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 33964514)
1. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program. Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514 [TBL] [Abstract][Full Text] [Related]
2. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program. Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804 [TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic? Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808 [TBL] [Abstract][Full Text] [Related]
6. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts. Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721 [TBL] [Abstract][Full Text] [Related]
7. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program. Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE Front Immunol; 2022; 13():937900. PubMed ID: 36203566 [TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695 [TBL] [Abstract][Full Text] [Related]
9. Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience. Guo M; Liu J; Clark P; Ahmad S; Patel R; Varela JC; Mori S Int J Hematol; 2023 Mar; 117(3):428-437. PubMed ID: 36378406 [TBL] [Abstract][Full Text] [Related]
10. Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts. Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV Eur J Haematol; 2022 Jan; 108(1):61-72. PubMed ID: 34606661 [TBL] [Abstract][Full Text] [Related]
11. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic. Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic. Strzelec A; Gawlik-Rzemieniewska N; Klima A; Panek K; Helbig G In Vivo; 2024; 38(3):1271-1277. PubMed ID: 38688614 [TBL] [Abstract][Full Text] [Related]
14. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988 [TBL] [Abstract][Full Text] [Related]
15. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
16. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551 [TBL] [Abstract][Full Text] [Related]
17. The Viability of Hematopoietic Progenitor Cell Grafts after Cryopreservation Does Not Predict Delayed Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation. Fadeyi E; Mamo YT; Saha AK; Wilson E; Pomper G Lab Med; 2022 Sep; 53(5):509-513. PubMed ID: 35640044 [TBL] [Abstract][Full Text] [Related]
18. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases. Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183 [TBL] [Abstract][Full Text] [Related]
19. Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source. Johnstone BH; Woods JR; Goebel WS; Gu D; Lin CH; Miller HM; Musall KG; Sherry AM; Bailey BJ; Sims E; Sinn AL; Pollok KE; Spellman S; Auletta JJ; Woods EJ Transplant Cell Ther; 2023 Feb; 29(2):95.e1-95.e10. PubMed ID: 36402456 [TBL] [Abstract][Full Text] [Related]
20. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic. Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]